Vehicle Safety
Recalls Search 320,000+ NHTSA safety recalls Complaints 2.1M+ consumer safety complaints TSBs 4.7M technical service bulletins VIN Lookup Decode any vehicle VIN instantly OBD Codes 12,000+ diagnostic trouble codes Fuel Economy EPA MPG data for all vehicles Statistics Recall trends & safety analysis
Consumer Safety
Product Safety 9,700+ CPSC product recalls Food Safety 28,600+ FDA food recalls Pet Safety 1.3M FDA animal adverse events Drug Safety 17,500+ FDA drug recalls Device Safety 38,400+ FDA device recalls Workplace Safety 102,900+ OSHA injury reports
Infrastructure
Bridge Safety 624,000 bridge inspections Aviation Safety 30,000+ NTSB aviation events Dam Safety 92,600 dam safety records Water Safety 433,000+ public water systems Railroad Safety 438,000+ rail crossings Pipeline Safety 8,800+ pipeline incidents
Public Health
Nursing Homes 14,700 CMS rated facilities Environmental 80,000+ hazardous sites & releases

Browse Drug Recalls

1,076 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 1,076 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 1,076 FDA drug recalls in CA.

Clear
DateProductReasonClassFirm
Jun 14, 2019 Losartan Potassium, 50 mg tablets, 1000 count bottle, NDC 60429-317-10 CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the activ... Class II Golden State Medical Supply Inc.
Jun 13, 2019 Heparin Sodium 25,000 USP units per 250 mL (100 USP units per mL) in 5% Dextr... Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa pot... Class II B. Braun Medical Inc
Jun 10, 2019 Robafen DM, Generic for Robitussin DM, In each teaspoonful (5mL): Dextrometho... CGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralsto... Class II Preferred Pharmaceuticals, Inc
May 1, 2019 Losartan Potassium Tablets USP 25 mg 90 count bottle NDC 60429-316-90 Rx only... CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in... Class II Golden State Medical Supply Inc.
May 1, 2019 Losartan Potassium Tablets USP 100 mg 90 count bottle NDC 60429-318-90 Rx onl... CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in... Class II Golden State Medical Supply Inc.
May 1, 2019 Losartan Potassium Tablets USP 100 mg 1000 count bottle NDC 60429-318-10 Rx o... CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in... Class II Golden State Medical Supply Inc.
May 1, 2019 Losartan Potassium Tablets USP 25 mg 1000 count bottle NDC 60429-316-10 Rx on... CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in... Class II Golden State Medical Supply Inc.
May 1, 2019 Losartan Potassium Tablets USP 25 mg 30 count bottle NDC 60429-316-30 Rx only... CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in... Class II Golden State Medical Supply Inc.
Apr 30, 2019 Losartan Potassium Tab. USP 50mg, a) 30 count bottle (NDC 68788-0048-03) and ... CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in... Class II Preferred Pharmaceuticals, Inc
Apr 23, 2019 Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display box... Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil. Class I D.B.P. Distribution
Mar 22, 2019 Biotin 10 mg/mL Injection, 30 mL vial, Rx only, 511 S. Harbor Blvd., Building... Failed pH Specification: product does not meet pH label claim. Class III Auro Pharmacies Inc. DBA Central Drugs
Mar 14, 2019 Blue Fusion Capsules, 1- count blister pack, Distributed by: DNS Distribution... Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared ingr... Class I Ata International Inc
Mar 6, 2019 Losartan Potassium Tablets, USP, 50 mg, a) 30-count bottle (NDC: 68788-0048-0... CGMP Deviations: presence of an impurity, N-Methylnitrosobutyric acid (NMBA) was identified. Class II Preferred Pharmaceuticals, Inc
Mar 4, 2019 Losartan Potassium 100 mg Tablets # 30 Losartan potassium tablets USP, 100 m... CGMP Deviations:Traces amounts of N-Nitroso N-Methyl 4- amino butyric acid (NMBA) impurity found ... Class II H J Harkins Company Inc dba Pharma Pac
Feb 19, 2019 Cefuroxime 10 mg/mL in Sodium Chloride, Intravitreal injection, 1 mL in a 2mL... Incorrect Product Formulation; compounded sterile drug reconstituted using sterile water instead ... Class II Leiter's Enterprises, Inc.
Feb 14, 2019 Dimercaptopropanesulfonate Sodium (DMPS), Aqueous injection solution, 50mg/mL... Presence of Particulate Matter: Particulates observed in vials release for dispensing. Class II McGuff Compounding Pharmacy Services, Inc.
Jan 25, 2019 the silver bullet 10x Capsules, 725 mg each (proprietary blend of: Mucuna Pru... Marketed without an Approved NDA/ANDA; FDA analysis found product to be tainted with undeclared s... Class I Natures Rx
Jan 10, 2019 Lipoic Acid Injection (aka Alpha Lipoic Acid or Thioctic Acid), 1,200 mg/30 m... Presence of Particulate Matter: filmy/cloudy particulate observed in vial. Class II McGuff Compounding Pharmacy Services, Inc.
Dec 11, 2018 Dyural-80 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Eno... Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recall... Class I Asclemed USA Inc. dba Enovachem
Dec 11, 2018 Dyural-40 Injection Kit, 1 Dose, Single Use Only, Rx only, Distributed by Eno... Labeling: Not eslewhere classified - The kits include Sodium Chloride, USP, 0.9% which was recall... Class I Asclemed USA Inc. dba Enovachem
Nov 5, 2018 puriton EYE RELIEF DROPS, 0.5 oz (15 ml) bottle, Kadesh Inc., NDC#7079600115,... Non-Sterility: Product manufactured under non-sterile production conditions. Class I Kadesh International
Nov 2, 2018 IRBESARTAN Tablets, USP 75 mg 90-count bottle, Rx Only, Manufactured by: SciG... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine ... Class II Golden State Medical Supply Inc.
Nov 2, 2018 IRBESARTAN Tablets, USP 150 mg (a) 30-count bottle (NDC 60429-641-30), (b) 90... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine ... Class II Golden State Medical Supply Inc.
Nov 2, 2018 IRBESARTAN Tablets, USP 300 mg (a) 30-count bottle (NDC 60429-642-30), (b) 90... CGMP Deviations: FDA laboratory testing confirmed presence of an impurity, N-nitrosodiethylamine ... Class II Golden State Medical Supply Inc.
Oct 18, 2018 GENTAMICIN OPTH-SOL 5ml Compare: Garamycin. 5-mL plastic dropper bottle, Mfg... Presence of Particulate Matter: Crystalline particles were noticed by manufacturer at the 24 mont... Class II H J Harkins Company Inc dba Pharma Pac
Oct 5, 2018 Contrave (naltrexone HCl and bupropion HCl). Extended-Release Tablets, 8mg/90... Container packaging defect. Class III Orexigen Therapeutics, Inc.
Aug 30, 2018 Thyroid powder, 4.5 kg foil bag, 5x1 kg foil bags packed in 25 Kg Fiber Drum,... CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels... Class II Alkano Chemicals, Inc
Aug 23, 2018 Cefuroxime 10mg/mL INJ 0.5 mg, SDV, Rx only, Pacific Compounding, Stockton, CA Presence of Particulate Matter: Particulate matter was reported in one lot of Cefuroxime by a phy... Class II Pacific Compounding Pharmacy & Consultations Inc
Aug 21, 2018 Calcium Gluconate injectable, 10%, 50 ml Single Dose vial, Rx only, Central D... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Methyl-Cobalamin injectable, 10 mg/mL, 30 mL Multiple Dose vial, Rx only, Cen... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Folic Acid injectable, 10 mg/ml, 30 ml Multiple Dose vial, Rx only, Central ... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Testosterone Enanthate/Cypionate injectable, 126/54 mg/mL, packaged in a) 3 m... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Methyl-Cobalamin injectable, 2 mg/mL, 30 ml Multiple Dose vial, Rx only, Cen... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Testosterone Cypionate/Enanthate injectable, 126/54 mg/mL, packaged in a) 3 m... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 CoEnzyme-Q10 injectable, 20 mg/mL, 10 mL Multiple Dose vial, Rx only, Central... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Dexpanthenol injectable, 250 mg/mL, 10 mL Single Dose vial, Rx only, Central ... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Glutathione injectable, 200 mg/mL, 30 mL Multiple Dose vial, Rx only, Central... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Testosterone Cypionate/Enanthate injectable, 200/50 mg/mL, packaged in a) 5 m... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Methyl-Cobalamin injectable, 5 mg/mL, 30 mL Multiple Dose vial, Rx only, Cent... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 21, 2018 Methyl-Cobalamin injectable, 1 mg/mL, packaged in a) 5 mL and b) 30 mL Multi... Lack of Assurance of Sterility: Inadequate processes and equipment to assure the sterility of pro... Class II Auro Pharmacies, Inc.
Aug 15, 2018 Valsartan Tablets USP 320 mg, 90-count, plastic child resistant bottle, Rx On... CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Class II Preferred Pharmaceuticals, Inc
Aug 9, 2018 Contrave (naltrexone HCl and bupropion HCl) Extended-Release Tablets, 8 mg/90... Defective Container: Customer complaints of punctures in the bottle. Class III Orexigen Therapeutics, Inc.
Jul 30, 2018 Valsartan/HCTZ 160/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Ph... CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Class II NuCare Pharmaceuticals Inc
Jul 30, 2018 Valsartan/HCTZ 160/12.5 mg Tablets, 90-count jar, Rx Only, Packaged by NuCare... CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Class II NuCare Pharmaceuticals Inc
Jul 30, 2018 Valsartan/HCTZ 320/25mg Tablets, 30-count jar, Rx Only, Packaged by NuCare Ph... CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Class II NuCare Pharmaceuticals Inc
Jul 27, 2018 Valsartan 320 mg tablets, 30-count bottles ( NDC 63629-6905-1), 90-count bott... CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Class II Bryant Ranch Prepack Inc.
Jul 27, 2018 Valsartan 320 mg tablets, 90-count bottles ( NDC 71335-0567-2), Rx Only, Pack... CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Class II Bryant Ranch Prepack Inc.
Jul 27, 2018 Valsartan 80 mg tablets, 90-count bottles (NDC 63629-6922-2), 60-count bottle... CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product. Class II Bryant Ranch Prepack Inc.
Jul 26, 2018 Valsartan tablets 160 mg, 90-count bottle, Rx Only, Repackaged by H.J. Harkin... Carcinogen impurity detected in API used to manufacture drug product. Class II H J Harkins Company Inc dba Pharma Pac
Jun 27, 2018 Enalapril Maleate, USP 5MG, 90-count bottle, RX only. Packaged By: Aidarex Ph... Out-of-specification results for the Enalapril Diketopiperazine degradation product during commer... Class III Aidarex Pharmaceuticals LLC

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.